Is CB or VRTX cheaper?

On trailing earnings, CB is cheaper: CB trades at a 11.59 P/E and VRTX at 26.39.

Which has grown faster, CB or VRTX?

Over the past five years, VRTX grew revenue faster — CB at a 9.76% CAGR versus VRTX at 13.82%.

Does CB or VRTX pay a bigger dividend?

CB pays a dividend (1.20% yield) while VRTX does not currently pay one.

Is CB or VRTX more profitable?

VRTX runs the higher net margin — CB at 18.48% versus VRTX at 35.40%.

Which has been the better investment, CB or VRTX?

Over the past 10-year, VRTX delivered the higher annualized total return — CB at 12.13% versus VRTX at 17.13%. Past performance doesn't predict future results.

Chubb Limited (CB) vs Vertex Pharmaceuticals Incorporated (VRTX)

VRTX leads on 7 of 13 compared metrics, though CB is the cheaper stock.

A side-by-side comparison of Chubb Limited and Vertex Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Chubb Limited

$127.27B

$328.14Financial Services

VRTX

Vertex Pharmaceuticals Incorporated

$112.92B

$444.93Healthcare

Total return — CB vs VRTX

growth of $100 · last 30y

CB +2093.4%VRTX +2424.4%VRTX compounded faster

CB VRTX

CB vs VRTX: by the numbers

•CB is the larger company ($127.27B vs $112.92B market cap).
•CB trades at the lower earnings multiple (11.59 vs 26.39 P/E).
•VRTX converts more revenue to profit (35.40% vs 18.48% net margin).
•VRTX grew revenue faster over the past five years (13.82% vs 9.76% CAGR).
•CB pays a dividend (1.20% yield) while VRTX does not currently pay one.

Which is better, CB or VRTX?

Metric tally: CB 6 · VRTX 7

It depends on what you're optimizing for:

ValueCB(lower P/E)

GrowthVRTX(faster 5Y revenue CAGR)

QualityVRTX(higher ROIC)

Metrics side by side

Valuation

Metric	CB	VRTX
P/E ratio	11.59●	26.39
Forward P/E	12.11●	20.58
P/S ratio	2.12●	9.31
P/B ratio	1.75●	5.89
PEG ratio	0.93●	3.23
EV / EBITDA	—	20.72
FCF yield	—	3.25%

Profitability

Metric	CB	VRTX
Gross margin	35.20%	86.28%●
Operating margin	18.61%	38.97%●
Net margin	18.48%	35.40%●
ROE	15.31%	22.41%●
ROIC	7.95%	18.12%●

Dividends

Metric	CB	VRTX
Dividend yield	1.20%	—
Payout ratio	15.17%	—

Growth (annualized)

Metric	CB	VRTX
Revenue CAGR (5Y)	9.76%	13.82%●
EPS CAGR (5Y)	27.08%●	8.17%
FCF CAGR (5Y)	—	4.01%
Total return CAGR (5Y)	16.27%	18.17%●

Frequently asked

Which is better, CB or VRTX?: It depends on your goal. value: CB (lower P/E); growth: VRTX (faster 5Y revenue CAGR); quality: VRTX (higher ROIC). Across all compared metrics, VRTX leads 7 to 6.
Is CB or VRTX cheaper?: On trailing earnings, CB is cheaper: CB trades at a 11.59 P/E and VRTX at 26.39.
Which has grown faster, CB or VRTX?: Over the past five years, VRTX grew revenue faster — CB at a 9.76% CAGR versus VRTX at 13.82%.
Does CB or VRTX pay a bigger dividend?: CB pays a dividend (1.20% yield) while VRTX does not currently pay one.
Is CB or VRTX more profitable?: VRTX runs the higher net margin — CB at 18.48% versus VRTX at 35.40%.
Which has been the better investment, CB or VRTX?: Over the past 10-year, VRTX delivered the higher annualized total return — CB at 12.13% versus VRTX at 17.13%. Past performance doesn't predict future results.

Go deeper

Full CB analysis Full VRTX analysis Interactive comparison tool

Dig into the metrics

Chubb P/E ratio Vertex Pharmaceuticals P/E ratio Chubb dividend yield Vertex Pharmaceuticals dividend yield Chubb ROE Vertex Pharmaceuticals ROE Chubb operating margin Vertex Pharmaceuticals operating margin Chubb revenue growth Vertex Pharmaceuticals revenue growth Chubb free cash flow Vertex Pharmaceuticals free cash flow

Chubb & Vertex Pharmaceuticals appear in these rankings

Dividend Aristocrats Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.